MXC.AX - MGC Pharmaceuticals Limited

ASX - ASX Delayed price. Currency in AUD

MGC Pharmaceuticals Limited

1202 Hay Street
West Perth, WA 6005
61 8 6382 3390

IndustryDrug Manufacturers—Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Roby Reuven ZomerCo-Founder, CEO, MD & Exec. Director484.63kN/A1980
Mr. Tom CairnsChief Accounting OfficerN/AN/AN/A
Ms. Yifat SteuerDeputy CEO & COON/AN/AN/A
Ms. Nicole Ann GodresseGlobal Chief Sales OfficerN/AN/AN/A
Mr. Amir PolakChief Pharmaceutical Devel. OfficerN/AN/AN/A
Ms. Sabina SuljakovicHead of the Quality Assurance DepartmentN/AN/AN/A
Dr. Nadya LisovoderChief Medical OfficerN/AN/AN/A
Ms. Sasha FriedmanDeputy CEON/AN/AN/A
Yair TalChief Information Security OfficerN/AN/AN/A
Mr. Robert ClementsChief Commercial OfficerN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. The company also provides ArtemiC range of products and cannabinoid products, as well as non-pharma products. In addition, it offers consulting services, including clinical research services. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is based in West Perth, Australia.

Corporate governance

MGC Pharmaceuticals Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.